These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22082991)

  • 21. The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome.
    Oksefjell H; Sandstad B; Tropé C
    Eur J Gynaecol Oncol; 2011; 32(4):369-76. PubMed ID: 21941955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
    Chi DS; Phaëton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
    Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of bowel obstruction in patients with advanced ovarian cancer.
    Zoetmulder FA; Helmerhorst TJ; van Coevorden F; Wolfs PE; Leyer JP; Hart AA
    Eur J Cancer; 1994; 30A(11):1625-8. PubMed ID: 7833134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of surgery after systemic treatment with the humanized recombinant antibody bevacizumab in heavily pretreated patients with advanced epithelial ovarian cancer.
    Sehouli J; Papanikolaou G; Braicu EI; Pietzner K; Neuhaus P; Fotopoulou C
    Ann Surg Oncol; 2012 Apr; 19(4):1326-33. PubMed ID: 22090022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Benefit of palliative surgery for bowel obstruction in recurrent ovarian carcinoma].
    Li ZT; Wu XH; Fu SL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):260-3. PubMed ID: 15130355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
    Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
    [No Abstract]   [Full Text] [Related]  

  • 28. Obesity-associated adipokines correlate with survival in epithelial ovarian cancer.
    Diaz ES; Karlan BY; Li AJ
    Gynecol Oncol; 2013 May; 129(2):353-7. PubMed ID: 23402904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
    Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
    Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.
    Deraco M; Kusamura S; Virzì S; Puccio F; Macrì A; Famulari C; Solazzo M; Bonomi S; Iusco DR; Baratti D
    Gynecol Oncol; 2011 Aug; 122(2):215-20. PubMed ID: 21665254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.
    Eoh KJ; Yoon JW; Lee I; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    J Surg Oncol; 2017 Sep; 116(3):329-336. PubMed ID: 28542980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
    Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
    J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
    Solmaz U; Mat E; Dereli ML; Turan V; Peker N; Tosun G; Dogan A; Adiyeke M; Ozdemir A; Gungorduk K; Sanci M; Yildirim Y
    J BUON; 2015; 20(3):847-54. PubMed ID: 26214639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival.
    Clarke-Pearson DL; Chin NO; DeLong ER; Rice R; Creasman WT
    Gynecol Oncol; 1987 Jan; 26(1):11-8. PubMed ID: 2431962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis.
    Mangili G; Aletti G; Frigerio L; Franchi M; Panacci N; Viganò R; DE Marzi P; Zanetto F; Ferrari A
    Int J Gynecol Cancer; 2005; 15(5):830-5. PubMed ID: 16174232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
    Chekerov R; Braicu I; Castillo-Tong DC; Richter R; Cadron I; Mahner S; Woelber L; Marth C; Van Gorp T; Speiser P; Zeillinger R; Vergote I; Sehouli J
    Int J Gynecol Cancer; 2013 Feb; 23(2):268-75. PubMed ID: 23358178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
    Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
    Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?
    Fotopoulou C; Savvatis K; Kosian P; Braicu IE; Papanikolaou G; Pietzner K; Schmidt SC; Sehouli J
    Br J Cancer; 2013 Jan; 108(1):32-8. PubMed ID: 23321509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer.
    Higashi H; Shida H; Ban K; Yamagata S; Masuda K; Imanari T; Yamamoto T
    Jpn J Clin Oncol; 2003 Jul; 33(7):357-9. PubMed ID: 12949063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
    Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
    Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.